What is the recommended treatment for a 36-year-old male with epididymitis who engages in anal sex and is likely infected with Chlamydia trachomatis (C. trachomatis) and Neisseria gonorrhoeae (N. gonorrhoeae)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a 36-year-old male with epididymitis who engages in anal sex and likely has C. trachomatis and N. gonorrhoeae infection, the recommended treatment is a combination of ceftriaxone 500 mg as a single intramuscular dose plus doxycycline 100 mg orally twice daily for 10 days. This dual therapy is essential because men who have sex with men are at higher risk for both pathogens simultaneously, as noted in the guidelines 1. Ceftriaxone effectively treats N. gonorrhoeae while doxycycline addresses C. trachomatis. The patient should abstain from sexual activity until treatment is completed and symptoms have resolved, typically within 1-2 weeks. Partners from the previous 60 days should also be notified, tested, and treated to prevent reinfection, as recommended in the 1993 sexually transmitted diseases treatment guidelines 1.

Some key points to consider in the treatment of epididymitis include:

  • The importance of treating both C. trachomatis and N. gonorrhoeae due to the high risk of co-infection in men who have sex with men 1.
  • The use of ceftriaxone as the preferred treatment for N. gonorrhoeae due to its effectiveness and the increasing resistance to other antibiotics, such as cefixime 1.
  • The recommendation for doxycycline as the treatment for C. trachomatis, as outlined in the 2002 sexually transmitted diseases treatment guidelines 1.
  • The need for supportive measures, such as bed rest, scrotal elevation, and anti-inflammatory medications like ibuprofen, to manage pain and swelling, as suggested in the 2002 guidelines 1.

It is crucial to follow the most recent and highest quality guidelines for the treatment of epididymitis, taking into account the increasing resistance of N. gonorrhoeae to certain antibiotics, as reported in the 2012 interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults 1. If symptoms don't improve within 72 hours, the patient should return for reevaluation to rule out other conditions or antibiotic resistance. This regimen targets both common causative organisms while providing adequate tissue penetration to the epididymis, ensuring effective clearance of the infection.

From the FDA Drug Label

Acute epididymo-orchitis caused by N. gonorrhoeae: 100 mg, by mouth, twice a day for at least 10 days. Acute epididymo-orchitis caused by C. trachomatis: 100 mg, by mouth, twice a day for at least 10 days

The recommended treatment for a 36-year-old male with epididymitis who engages in anal sex and is likely infected with Chlamydia trachomatis (C. trachomatis) and Neisseria gonorrhoeae (N. gonorrhoeae) is doxycycline (PO) 100 mg, by mouth, twice a day for at least 10 days 2.

  • Key points:
    • The patient should be treated for both C. trachomatis and N. gonorrhoeae.
    • Doxycycline is the recommended antibiotic for the treatment of epididymitis caused by C. trachomatis and N. gonorrhoeae.
    • The dosage is 100 mg, by mouth, twice a day for at least 10 days.
  • Clinical reasoning: The treatment is based on the recommended dosage and duration for the treatment of acute epididymo-orchitis caused by C. trachomatis and N. gonorrhoeae.

From the Research

Treatment for Epididymitis

The recommended treatment for a 36-year-old male with epididymitis who engages in anal sex and is likely infected with Chlamydia trachomatis (C. trachomatis) and Neisseria gonorrhoeae (N. gonorrhoeae) is as follows:

  • A single intramuscular dose of ceftriaxone with 10 days of oral doxycycline is the treatment of choice for sexually active males 14 to 35 years of age 3.
  • However, since the patient is 36 years old and engages in insertive anal intercourse, an enteric organism is also likely, and ceftriaxone with 10 days of oral levofloxacin or ofloxacin is the recommended treatment regimen 3.
  • The treatment targets the most common pathogens, including C. trachomatis and N. gonorrhoeae, as well as enteric bacteria 4.

Clinical Reasoning

The clinical reasoning behind this treatment is based on the following:

  • The patient's age and sexual practices increase the risk of infection with C. trachomatis and N. gonorrhoeae 3, 5.
  • The patient's symptoms, such as scrotal pain and urinary symptoms, are consistent with epididymitis 3, 4.
  • The treatment regimen is empirical and targets the most common pathogens, with the goal of reducing patient morbidity and preventing complications such as infertility and chronic scrotal pain 3, 4.

Dosage and Duration

The recommended dosage and duration of treatment are as follows:

  • Ceftriaxone: a single intramuscular dose 3.
  • Doxycycline: 10 days of oral treatment 3.
  • Levofloxacin or ofloxacin: 10 days of oral treatment 3. It is essential to note that the treatment regimen may vary depending on the patient's specific circumstances and the results of laboratory tests 4, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Epididymitis: An Overview.

American family physician, 2016

Research

Epididymitis and orchitis: an overview.

American family physician, 2009

Research

Epididymitis, orchitis, and related conditions.

Sexually transmitted diseases, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.